Friday, 31 March 2017

NIAID begins vaccinations in a mid-stage trial for Zika

(Reuters) - The U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Friday that vaccinations have begun in a mid-stage trial testing an experimental DNA vaccine for Zika.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)